The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against using testosterone therapy in healthy girls. Although the FDA approved testosterone therapy for the treatment of ailments involving the testes, pituitary and hypothalamus, it has not been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the security of testosterone. The study involved nearly 800 elderly men with low testosterone and symptoms associated with this condition, for example http://tinyurl.com/jdmk5rh sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment since the men's heart health was carefully tracked.
Studies have shown that testosterone deficiency is associated with several significant health issues such as metabolic syndrome, obesity, diabetes, and bone fractures Men who meet medical criteria for treatment should get therapy. In reality, your testosterone levels have probably been slowly declining for some time, a downfall that usually begins around age 30.
And many women have a knee jerk feeling that any hormone treatment can raise their risk of breast cancer. However, clinical studies demonstrate that testosterone not only does not increase a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will probably stay the status quo for some time, given the prohibitive cost of running the long term safety studies needed to acquire FDA approval that is more total.